Public Health Responsibilities in the Era of GLP-1 Receptor Agonists

J Public Health Manag Pract. 2024 Nov-Dec;30(6):777-779. doi: 10.1097/PHH.0000000000002039. Epub 2024 Aug 22.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Glucagon-Like Peptide-1 Receptor* / agonists
  • Humans
  • Public Health* / methods
  • Public Health* / trends

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Glucagon-Like Peptide-1 Receptor Agonists